Plasma membrane redox enzymes: new therapeutic targets for neurodegenerative diseases

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


Mitochondrial dysfunction caused by oxidative stress appears at early stages of aging and age-related diseases. Plasma membrane redox enzymes act in a compensatory manner to decrease oxidative stress and supply reductive capacity to ensure cell survival. Plasma membrane redox enzymes transfer electrons from NAD(P)H to oxidized ubiquinone and α-tocopherol, resulting in inhibition of further oxidative damage. Plasma membrane redox enzymes and their partners are affected by aging, leading to progression of neurodegenerative disease pathogenesis. Up-regulating plasma membrane redox enzymes via calorie restriction and phytochemicals make cells more resistant to oxidative damage under stress conditions by maintaining redox homeostasis and improving mitochondrial function. Investigation into plasma membrane redox enzymes can provide mechanistic details underlying the relationships between plasma membrane redox enzymes and mitochondrial complexes and provide a good therapeutic target for prevention and delay of neurodegenerative disorders.

Original languageEnglish
Pages (from-to)436-445
Number of pages10
JournalArchives of Pharmacal Research
Issue number5
StatePublished - 1 May 2019


  • Mitochondrial dysfunction
  • Neurodegenerative diseases
  • Oxidative stress
  • Plasma membrane redox enzymes


Dive into the research topics of 'Plasma membrane redox enzymes: new therapeutic targets for neurodegenerative diseases'. Together they form a unique fingerprint.

Cite this